Enorama Pharma AB(SE:ERMA)
kr 0.49-0.21 (-29.60%)
SE:ERMA
Enorama Pharma AB financials statements
kr 0.49
At close:-0.21 (-29.60%)
Want to see SE:ERMA full AI Analyst Report?
Enorama Pharma AB (ERMA) Ratios
0 Followers
Enorama Pharma AB Ratios
SE:ERMA's free cash flow for Q2 2026 was kr-14.97M. For the 2026 fiscal year, SE:ERMA's free cash flow was increased by kr0.00 and operating cash flow was kr-14.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.25 | 1.87 | 1.27 | 0.95 | 1.92 |
| Quick Ratio | 0.20 | 0.48 | 0.85 | 0.72 | 1.92 |
| Cash Ratio | 0.10 | 0.26 | 0.60 | 0.33 | 1.04 |
| Solvency Ratio | -2.35 | -2.89 | -2.96 | -2.22 | -0.94 |
| Operating Cash Flow Ratio | -1.87 | -4.41 | -4.05 | -2.65 | -2.58 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -310.89 | -22.51 | -14.45 |
| Net Current Asset Value | kr -23.72M | kr 7.07M | kr -1.88M | kr -5.45M | kr -7.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.04 | 0.07 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.02 | 0.06 | 0.18 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.06 | 0.15 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.01 | 0.07 |
| Financial Leverage Ratio | -0.35 | 2.04 | 1.76 | 1.55 | 2.39 |
| Debt Service Coverage Ratio | -4.88 | -6.82 | -42.38 | -13.51 | -9.37 |
| Interest Coverage Ratio | -4.91 | -15.89 | -47.38 | -32.58 | -33.59 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.07 | 0.03 |
| Interest Debt Per Share | 0.18 | 0.06 | 0.04 | 0.34 | 0.61 |
| Net Debt to EBITDA | 0.05 | 0.10 | 0.13 | 0.06 | 0.32 |
| Profitability Margins | |||||
| Gross Profit Margin | -2255.60% | 23.48% | -287.26% | -9.00% | 19.34% |
| EBIT Margin | -2267.98% | -258.85% | -3220.18% | -595.25% | -244.11% |
| EBITDA Margin | -2250.86% | -129.41% | -3170.32% | -543.60% | -238.10% |
| Operating Profit Margin | -2267.98% | -301.34% | -3080.85% | -605.67% | -244.11% |
| Pretax Profit Margin | -2743.30% | -277.82% | -3285.20% | -613.85% | -251.38% |
| Net Profit Margin | -2743.30% | -277.82% | -3285.20% | -610.19% | -258.64% |
| Continuous Operations Profit Margin | -2743.30% | -277.82% | -3285.20% | -613.85% | -251.38% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 99.41% | 102.89% |
| EBT Per EBIT | 120.96% | 92.19% | 106.63% | 101.35% | 102.98% |
| Return on Assets (ROA) | -909.45% | -275.61% | -129.75% | -85.75% | -56.04% |
| Return on Equity (ROE) | 320.41% | -561.40% | -228.34% | -132.53% | -133.67% |
| Return on Capital Employed (ROCE) | 264.89% | -608.93% | -173.12% | -114.26% | -68.63% |
| Return on Invested Capital (ROIC) | 264.89% | -608.93% | -172.17% | -109.17% | -65.16% |
| Return on Tangible Assets | -938.30% | -286.28% | -322.67% | -165.20% | -115.89% |
| Earnings Yield | -56.62% | -24.58% | -52.92% | -149.27% | -21.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.03 | 11.19 | 0.66 | 1.58 | 1.30 |
| Payables Turnover | 9.92 | 10.33 | 1.41 | 1.39 | 4.08 |
| Inventory Turnover | 36.87 | 1.07 | 1.23 | 2.63 | 0.00 |
| Fixed Asset Turnover | 228.25 | 111.04 | 1.58 | 4.45 | 4.97 |
| Asset Turnover | 0.33 | 0.99 | 0.04 | 0.14 | 0.22 |
| Working Capital Turnover Ratio | -0.33 | 3.21 | 1.31 | 1.36 | 4.47 |
| Cash Conversion Cycle | 325.86 | 338.38 | 591.17 | 107.34 | 191.81 |
| Days of Sales Outstanding | 352.74 | 32.62 | 551.26 | 230.40 | 281.19 |
| Days of Inventory Outstanding | 9.90 | 341.10 | 297.89 | 138.75 | 0.00 |
| Days of Payables Outstanding | 36.78 | 35.34 | 257.98 | 261.80 | 89.38 |
| Operating Cycle | 362.64 | 373.72 | 849.15 | 369.15 | 281.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.85 | -0.67 | -1.23 | -3.47 | -4.01 |
| Free Cash Flow Per Share | -0.85 | -0.67 | -1.23 | -3.47 | -4.26 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | -16.55 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | -16.55 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -94.84 | -17.26 | -7.96 |
| Operating Cash Flow to Sales Ratio | -21.64 | -2.26 | -30.45 | -4.81 | -2.73 |
| Free Cash Flow Yield | -44.66% | -20.03% | -49.05% | -117.75% | -23.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.77 | -4.05 | -1.89 | -0.67 | -4.73 |
| Price-to-Sales (P/S) Ratio | 48.45 | 11.30 | 62.07 | 4.09 | 12.25 |
| Price-to-Book (P/B) Ratio | -5.66 | 22.84 | 4.31 | 0.89 | 6.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.24 | -4.99 | -2.04 | -0.85 | -4.23 |
| Price-to-Operating Cash Flow Ratio | -2.24 | -4.99 | -2.04 | -0.85 | -4.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | 0.11 | 0.03 | -0.04 | -0.64 |
| Enterprise Value Multiple | -2.10 | -8.63 | -1.83 | -0.69 | -4.82 |
| Enterprise Value | 129.66M | 176.12M | 78.58M | 25.76M | 126.74M |
| EV to EBITDA | -2.10 | -8.63 | -1.83 | -0.69 | -4.82 |
| EV to Sales | 47.34 | 11.17 | 57.86 | 3.76 | 11.48 |
| EV to Free Cash Flow | -2.19 | -4.93 | -1.90 | -0.78 | -3.96 |
| EV to Operating Cash Flow | -2.19 | -4.93 | -1.90 | -0.78 | -4.20 |
| Tangible Book Value Per Share | -0.34 | 0.14 | -0.03 | 0.85 | -0.66 |
| Shareholders’ Equity Per Share | -0.34 | 0.15 | 0.58 | 3.32 | 2.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.03 |
| Revenue Per Share | 0.04 | 0.30 | 0.04 | 0.72 | 1.47 |
| Net Income Per Share | -1.08 | -0.83 | -1.33 | -4.40 | -3.80 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.03 |
| Interest Burden | 1.21 | 1.07 | 1.02 | 1.03 | 1.03 |
| Research & Development to Revenue | 0.00 | 1.27 | 2.11 | 0.42 | -0.16 |
| SG&A to Revenue | 0.00 | 1.97 | 0.00 | 0.00 | 1.62 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 0.75 | 0.93 | 0.79 | 1.12 |
Currency in SEK

